Oura Targets Up to $15.6 Billion Valuation in IPO, Surpassing Prada and Lululemon
Oura, a health-tracking smart ring company, aims for a $15.6 billion valuation in its U.S. IPO, selling 50 million shares at $40-$44 each, potentially raising $2.2 billion. The offering is set to price Sept. 29, with shares trading on Nasdaq under OURA. Oura reported $1.21 billion in revenue for the nine months ended June 30, up 74% year over year, with 5 million paid members.
How this was made

The 30-second read
Why it matters
The offering could become one of the largest consumer‑tech IPOs of the year, influencing pricing expectations for similar health‑tech companies.
Market read
Oura's IPO may reshape valuation multiples for wearable health devices and attract capital to the sector.
What to watch
Long‑term sustainability of subscription revenue and potential supply‑chain constraints.
Background
Oura, a Finnish‑origin smart‑ring maker, filed an IPO prospectus seeking up to $15.6 bn valuation, planning to list on Nasdaq under the ticker OURA.
Ticker impact
Oura announced a US IPO targeting a $15.6 billion valuation, selling 50 million shares at $40‑$44 each.
Initial trading likely to be volatile with upside if pricing hits $44; downside risk if demand weakens.
Large raise ($2.2 bn) and high valuation for a consumer‑tech firm create strong buying interest, but execution risk remains.
Market effects
Sets a new valuation benchmark for wearable‑tech and luxury‑fashion crossover companies.
Adds a high‑profile consumer‑tech offering to the US IPO pipeline.
Signals strong investor appetite for health‑tech listings worldwide.
Counterpoint
Valuation may be stretched given competition from established smartwatch makers.
Key entities
- companyOura
Smart‑ring health‑tracking company planning a US IPO.



